Investing in quality businesses is a smart move for both new and seasoned investors. It takes time, research, and patience to find the right stocks for your portfolio. Here are two top stocks worth considering for investors looking to invest $200 this month.
1. Pfizer
Pfizer (NYSE: PFE) has a long history as one of the largest pharmaceutical companies in the world. Despite the slowdown in growth before the pandemic, Pfizer’s development of COVID-19 products injected new growth into the business. The company achieved record profits and sales, surpassing $100 billion in annual sales in 2022. Strategic acquisitions, including the purchase of Seagen, have boosted Pfizer’s portfolio and pipeline. With a focus on expanding its oncology program, Pfizer remains a strong contender in the pharmaceutical industry.
In the first quarter of 2024, Pfizer reported revenue close to $15 billion, with growth in key products like Vyndaqel and Eliquis. Despite challenges, Pfizer’s profitability and dividend yield of nearly 6% make it an attractive investment option for long-term investors.
2. Fiverr
Fiverr International (NYSE: FVRR) operates a platform that connects freelancers with businesses for various tasks. As the gig economy continues to expand, Fiverr’s platform offers opportunities for freelancers and businesses alike. The company has been focusing on AI-centric projects and services, driving growth in complex services on its platform. Revenue in the first quarter of 2024 increased, with a strong focus on higher-quality services and AI-driven gigs.
While challenges persist, Fiverr’s initiatives to cater to larger companies and expand its service offerings position it well in the gig economy landscape. Investors looking to capitalize on the gig economy’s growth may find Fiverr a compelling investment option.
Should you invest $1,000 in Pfizer right now?
Before investing in Pfizer, consider the recommendations from the Motley Fool Stock Advisor analyst team, who have identified 10 stocks with potential for significant returns. While Pfizer may not be on their list, past recommendations like Nvidia have delivered impressive returns for investors.
*Stock Advisor returns as of July 22, 2024
Rachel Warren has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Fiverr International and Pfizer. The Motley Fool has a disclosure policy.
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $200 was originally published by The Motley Fool